These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 23481110)

  • 21. Microbiological diagnosis and antibiotic therapy in patients with community-acquired pneumonia and acute COPD exacerbation in daily clinical practice: comparison to current guidelines.
    Reissig A; Mempel C; Schumacher U; Copetti R; Gross F; Aliberti S
    Lung; 2013 Jun; 191(3):239-46. PubMed ID: 23564195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The role of atypical pathogen: Mycoplasma pneumoniae and Chlamydia pneumoniae in the acute respiratory infection in childhood].
    Ouchi K
    Jpn J Antibiot; 2000 Jun; 53 Suppl B():13-21. PubMed ID: 12572086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A comparison of moxifloxacin and amoxicillin in the treatment of community-acquired pneumonia in Latin America: results of a multicenter clinical trial].
    Jardim JR; Rico G; de la Roza C; Obispo E; Urueta J; Wolff M; Miravitlles M;
    Arch Bronconeumol; 2003 Sep; 39(9):387-93. PubMed ID: 12975069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The correct approach to community-acquired pneumonia in immunocompetent adults: review of current guidelines.
    Carbonara S; Stano F; Scotto G; Monno L; Angarano G
    New Microbiol; 2008 Jan; 31(1):1-18. PubMed ID: 18437837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines.
    Lim WS; Macfarlane JT; Boswell TC; Harrison TG; Rose D; Leinonen M; Saikku P
    Thorax; 2001 Apr; 56(4):296-301. PubMed ID: 11254821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of 'atypical pathogens' among adult hospitalized patients with community-acquired pneumonia.
    Lui G; Ip M; Lee N; Rainer TH; Man SY; Cockram CS; Antonio GE; Ng MH; Chan MH; Chau SS; Mak P; Chan PK; Ahuja AT; Sung JJ; Hui DS
    Respirology; 2009 Nov; 14(8):1098-105. PubMed ID: 19818051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Community-Acquired Pneumonia in the Asia-Pacific Region.
    Song JH; Huh K; Chung DR
    Semin Respir Crit Care Med; 2016 Dec; 37(6):839-854. PubMed ID: 27960208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Community-acquired pneumonia in children.
    Dennehy PH
    Med Health R I; 2010 Jul; 93(7):211-5. PubMed ID: 20704068
    [No Abstract]   [Full Text] [Related]  

  • 29. [ALAT (Latin American Thoracic Association) recommendations on community-acquired pneumonia].
    Luna CM; Ramírez J; López H; Mazzei JA; Abreu de Oliveira JC; Pereira J; Jardim JR; Gonzáles P; Lisboa C; Maldonado D; Torres C; Martínez Selmo S; Miravitlles M; Rodríguez de Castro F; Torres A; Anzueto A; Luna JM; Diaz M; Pérez Padilla R; Sansores R;
    Arch Bronconeumol; 2001 Sep; 37(8):340-8. PubMed ID: 11562320
    [No Abstract]   [Full Text] [Related]  

  • 30. Antibiotic use for community-acquired pneumonia in neonates and children: WHO evidence review.
    Mathur S; Fuchs A; Bielicki J; Van Den Anker J; Sharland M
    Paediatr Int Child Health; 2018 Nov; 38(sup1):S66-S75. PubMed ID: 29790844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology, clinical characteristics and antimicrobial resistance patterns of community-acquired pneumonia in 1702 hospitalized children in Singapore.
    Chiang WC; Teoh OH; Chong CY; Goh A; Tang JP; Chay OM
    Respirology; 2007 Mar; 12(2):254-61. PubMed ID: 17298459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Azithromycin and lower respiratory tract infections.
    Blasi F; Cazzola M; Tarsia P; Cosentini R; Aliberti S; Santus P; Allegra L
    Expert Opin Pharmacother; 2005 Oct; 6(13):2335-51. PubMed ID: 16218893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Community-acquired pneumonia in Chile: the clinical relevance in the detection of viruses and atypical bacteria.
    Luchsinger V; Ruiz M; Zunino E; Martínez MA; Machado C; Piedra PA; Fasce R; Ulloa MT; Fink MC; Lara P; Gebauer M; Chávez F; Avendaño LF
    Thorax; 2013 Nov; 68(11):1000-6. PubMed ID: 23783373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of respiratory viral infections among children hospitalized for community-acquired pneumonia in a developing country.
    Nascimento-Carvalho CM; Ribeiro CT; Cardoso MR; Barral A; Araújo-Neto CA; Oliveira JR; Sobral LS; Viriato D; Souza AL; Saukkoriipi A; Paldanius M; Vainionpää R; Leinonen M; Ruuskanen O
    Pediatr Infect Dis J; 2008 Oct; 27(10):939-41. PubMed ID: 18756190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changing needs of community-acquired pneumonia.
    Ramirez JA; Anzueto AR
    J Antimicrob Chemother; 2011 Apr; 66 Suppl 3(Suppl 3):iii3-9. PubMed ID: 21482567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Amoxicillin Dose and Treatment Duration on the Need for Antibiotic Re-treatment in Children With Community-Acquired Pneumonia: The CAP-IT Randomized Clinical Trial.
    Bielicki JA; Stöhr W; Barratt S; Dunn D; Naufal N; Roland D; Sturgeon K; Finn A; Rodriguez-Ruiz JP; Malhotra-Kumar S; Powell C; Faust SN; Alcock AE; Hall D; Robinson G; Hawcutt DB; Lyttle MD; Gibb DM; Sharland M;
    JAMA; 2021 Nov; 326(17):1713-1724. PubMed ID: 34726708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The aetiology of community-acquired pneumonia and implications for patient management.
    van Gageldonk-Lafeber AB; Wever PC; van der Lubben IM; de Jager CP; Meijer A; de Vries MC; Elberse K; van der Sande MA; van der Hoek W
    Neth J Med; 2013 Oct; 71(8):418-25. PubMed ID: 24127502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and economic outcomes in respiratory tract infections: The impact of bacterial resistance.
    Rapp RP
    Postgrad Med; 2002 Sep; 112(3 Suppl):12-7. PubMed ID: 19667590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relevance of healthcare-associated pneumonia for empirical antibiotic therapy in the Netherlands.
    Schweitzer VA; van Werkhoven CH; van Heijl I; Smits RF; Boel CHE; Bonten MJM; Postma DF; Oosterheert JJ
    Neth J Med; 2018 Nov; 76(9):389-396. PubMed ID: 30465653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Azithromycin plus β-lactam versus levofloxacin plus β-lactam for severe community-acquired pneumonia: A retrospective nationwide database analysis.
    Suzuki J; Sasabuchi Y; Hatakeyama S; Matsui H; Sasahara T; Morisawa Y; Yamada T; Yasunaga H
    J Infect Chemother; 2019 Dec; 25(12):1012-1018. PubMed ID: 31227381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.